Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1503/cmaj.241440 | DOI Listing |
During May-December 2024, we detected Oropouche virus (OROV) in 13.9% (263/1,890) of febrile patients in Ceará state, Brazil. Genomic sequencing revealed those cases were caused by a novel OROV reassortant previously identified in the Amazon region.
View Article and Find Full Text PDFClin Chem
March 2025
Department of Laboratory Medicine and Pathology, Division of Clinical Microbiology, Mayo Clinic, Rochester, MN, United States.
In 2024, a novel recombinant of the Oropouche virus emerged as a potential threat. This virus has caused a significant outbreak in Brazil and Cuba, with imported cases subsequently reported in the USA and Europe. This review summarises the existing knowledge on the Oropouche virus, and discusses potential risk mitigation strategies for the transfusion community.
View Article and Find Full Text PDFCMAJ
March 2025
Department of Medicine (Dinh, Kanji, Vaughan), Cumming School of Medicine, University of Calgary and Alberta Health Services; Provincial Public Health Laboratory (Kanji), Alberta Health Services; Calvin, Phoebe, and Joan Snyder Institute for Chronic Diseases (Vaughan), University of Calgary and Alberta Health Services, Calgary, Alta.
We describe introduction of the 2022-2023 Oropouche virus lineage from Brazil, which has caused large-scale outbreaks throughout Brazil, into the Amazon Region of Peru. This lineage is co-circulating with another lineage that was circulating previously. Our findings highlight the need for continued surveillance to monitor Oropouche virus in Peru.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!